ADMA Biologics, Inc. (ADMA)
9.62
+0.04
(+0.42%)
USD |
NASDAQ |
Sep 04, 16:00
9.52
-0.10
(-1.04%)
After-Hours: 20:00
ADMA Biologics SG&A Expense (TTM) : 103.25M for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 103.25M |
| March 31, 2026 | 98.86M |
| December 31, 2025 | 96.42M |
| September 30, 2025 | 96.37M |
| June 30, 2025 | 92.91M |
| March 31, 2025 | 87.09M |
| December 31, 2024 | 78.37M |
| September 30, 2024 | 70.00M |
| June 30, 2024 | 65.61M |
| March 31, 2024 | 63.64M |
| December 31, 2023 | 63.29M |
| September 30, 2023 | 66.05M |
| June 30, 2023 | 68.61M |
| March 31, 2023 | 68.92M |
| December 31, 2022 | 70.30M |
| September 30, 2022 | 67.11M |
| June 30, 2022 | 63.23M |
| March 31, 2022 | 60.58M |
| December 31, 2021 | 55.19M |
| September 30, 2021 | 48.69M |
| June 30, 2021 | 45.15M |
| March 31, 2021 | 41.49M |
| December 31, 2020 | 37.65M |
| September 30, 2020 | 35.38M |
| June 30, 2020 | 32.70M |
| Date | Value |
|---|---|
| March 31, 2020 | 29.80M |
| December 31, 2019 | 27.62M |
| September 30, 2019 | 29.98M |
| June 30, 2019 | 29.65M |
| March 31, 2019 | 27.98M |
| December 31, 2018 | 26.74M |
| September 30, 2018 | 22.53M |
| June 30, 2018 | 19.39M |
| March 31, 2018 | 18.82M |
| December 31, 2017 | 18.09M |
| September 30, 2017 | 16.19M |
| June 30, 2017 | 13.78M |
| March 31, 2017 | 11.06M |
| December 31, 2016 | 8.495M |
| September 30, 2016 | 7.096M |
| June 30, 2016 | 7.395M |
| March 31, 2016 | 7.108M |
| December 31, 2015 | 6.746M |
| September 30, 2015 | 5.974M |
| June 30, 2015 | 4.931M |
| March 31, 2015 | 5.035M |
| December 31, 2014 | 4.824M |
| September 30, 2014 | 4.710M |
| June 30, 2014 | 5.178M |
| March 31, 2014 | 5.267M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Erasca, Inc. | 41.80M |
| Vericel Corp. | 180.98M |
| Emergent BioSolutions, Inc. | 181.20M |
| Exelixis, Inc. | 533.92M |
| Krystal Biotech, Inc. | 159.89M |